Acuamark Diagnostics Secures $11.3 Million In Series A Funding
Acuamark Diagnostics, an early cancer detection company, today announced the closing of an $11.3 million Series A round. The round was led by the office of Claudio Del Vecchio and the Del Vecchio Family Foundation, and it was joined by Bruker Corporation as a new investor in AcuamarkDx. Claudio Del Vecchio has joined AcuamarkDx’s Board of Directors. AcuamarkDx is a molecular diagnostics … Read more